![LEFT ATRIAL STRAIN AS A SURROGATE MARKER OF ATRIAL CHAMBER STIFFNESS | Journal of the American College of Cardiology LEFT ATRIAL STRAIN AS A SURROGATE MARKER OF ATRIAL CHAMBER STIFFNESS | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/e45df9a8-8f5c-4853-ab89-59d9bbf3a364/s0735-1097(19)32132-1.fp.png)
LEFT ATRIAL STRAIN AS A SURROGATE MARKER OF ATRIAL CHAMBER STIFFNESS | Journal of the American College of Cardiology
![MRI as a surrogate marker for clinical outcomes in multiple sclerosis | Personalized Management of Multiple Sclerosis MRI as a surrogate marker for clinical outcomes in multiple sclerosis | Personalized Management of Multiple Sclerosis](https://www.futuremedicine.com/cms/10.2217/ebo.12.509/asset/images/medium/figure1.gif)
MRI as a surrogate marker for clinical outcomes in multiple sclerosis | Personalized Management of Multiple Sclerosis
![REBEL Cast Episode 1: Clinically Important Biphasic Anaphylaxis & Total Lymphocyte Count as a Surrogate Marker for CD4 - REBEL EM - Emergency Medicine Blog REBEL Cast Episode 1: Clinically Important Biphasic Anaphylaxis & Total Lymphocyte Count as a Surrogate Marker for CD4 - REBEL EM - Emergency Medicine Blog](https://rebelem.com/wp-content/uploads/2014/07/REBEL-Cast-Episode-1-1024x575.png)
REBEL Cast Episode 1: Clinically Important Biphasic Anaphylaxis & Total Lymphocyte Count as a Surrogate Marker for CD4 - REBEL EM - Emergency Medicine Blog
![Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age | SpringerLink Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11357-022-00671-8/MediaObjects/11357_2022_671_Fig1_HTML.png)
Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age | SpringerLink
Tympanic membrane pressure (TMP) as a surrogate marker of intracranial... | Download Scientific Diagram
![Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity - Yongming Qu, 2013 Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity - Yongming Qu, 2013](https://journals.sagepub.com/cms/10.1177/1740774513499652/asset/images/large/10.1177_1740774513499652-fig1.jpeg)
Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity - Yongming Qu, 2013
![Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-021-01234-5/MediaObjects/12933_2021_1234_Fig1_HTML.png)
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
![2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram 2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram](https://www.researchgate.net/publication/40798768/figure/fig7/AS:408360974340102@1474372251459/Relationship-between-a-surrogate-marker-and-true-outcome-adjusted-for-this-thesis-28.png)
2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram
![Cancers | Free Full-Text | Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer Cancers | Free Full-Text | Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer](https://www.mdpi.com/cancers/cancers-13-03020/article_deploy/html/images/cancers-13-03020-g001.png)
Cancers | Free Full-Text | Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer
![The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology](https://bjcardio.co.uk/files/uploads/2008/09/2-table-1.png)
The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology
![Controlling HgBA1C with Medications Does not Make Diabetes Disappear - It Lowers the Surrogate Marker HgBA1C - APIM Controlling HgBA1C with Medications Does not Make Diabetes Disappear - It Lowers the Surrogate Marker HgBA1C - APIM](https://worldlinkmedical-uploads.azureedge.net/worldlinkmedical/2021/08/HbA1c-Test-Resized.png)